Copy to clipboard 
OrthoPediatrics (KIDS) posted 2Q18 revenue of US $15.1MM, +27.8% vs. 2Q17, and 1H18 revenue of $27.2MM, +26.0% vs. 1H17.
| 2Q18 | 2Q17 | $ Change | % Change | |
| Â Trauma | $9.9Â | $7.9Â | $2.0Â | 25.3%Â |
| Â Spine | $4.9Â | $3.4Â | $1.5Â | 42.7%Â |
| Â Arthroscopy/Soft Tissue Repair | $0.3Â | $0.5Â | -$0.2Â | -36.3%Â |
| Total | $15.1 | $11.8 | $3.3 | 27.8% |
| 1H18 | 1H17 | $ Change | % Change | |
|  Trauma | $19.0 | $15.6 | $3.4 | 21.6% |
| Â Spine | $7.6Â | $5.4Â | $2.2Â | 41.6%Â |
| Â Arthroscopy/Soft Tissue Repair | $0.6Â | $0.6Â | $0.0Â | 0.7%Â |
| Total | $27.2 | $21.6 | $5.6 | 26.0% |
Revenue by geographic region:
| 2Q18Â | 1H18Â | |
| Â U.S. | $11.5Â | $20.1Â |
| Â Ex-U.S. | $3.6Â | $7.1Â |
This is KIDS’ highest reported quarterly revenue ever. While Arthroscopy/Soft Tissue Repair is a very small portion of revenue, no explanation was given for the drop in growth.
KIDS continues to invest in consignment sets, R&D and salesforce expansion. They invested an additional $2.8MM in sets in the quarter, and remain on track to end the year having invested $11.0MM in total. (This is up from the $10.0MM cited in the 1Q earnings call.)
Thirteen domestic reps came on board in 2Q. Four additional systems will launch by year end, including the small stature RESPONSE scoliosis system and an additional BandLok device. R&D is said to be making progress on active growing implants and spinal tethering.
The company raised full-year revenue guidance from +22% vs. 2017; the range is now +23% to +%24% for upwards of $42.0MM.
Source: OrthoPediatrics, Inc.
OrthoPediatrics (KIDS) posted 2Q18 revenue of US $15.1MM, +27.8% vs. 2Q17, and 1H18 revenue of $27.2MM, +26.0% vs. 1H17.
Q18Â
Q17Â
$ ChangeÂ
% ChangeÂ
 Trauma
$9.9Â
$7.9Â
$2.0Â ...
OrthoPediatrics (KIDS) posted 2Q18 revenue of US $15.1MM, +27.8% vs. 2Q17, and 1H18 revenue of $27.2MM, +26.0% vs. 1H17.
| 2Q18 | 2Q17 | $ Change | % Change | |
| Â Trauma | $9.9Â | $7.9Â | $2.0Â | 25.3%Â |
| Â Spine | $4.9Â | $3.4Â | $1.5Â | 42.7%Â |
| Â Arthroscopy/Soft Tissue Repair | $0.3Â | $0.5Â | -$0.2Â | -36.3%Â |
| Total | $15.1 | $11.8 | $3.3 | 27.8% |
| 1H18 | 1H17 | $ Change | % Change | |
|  Trauma | $19.0 | $15.6 | $3.4 | 21.6% |
| Â Spine | $7.6Â | $5.4Â | $2.2Â | 41.6%Â |
| Â Arthroscopy/Soft Tissue Repair | $0.6Â | $0.6Â | $0.0Â | 0.7%Â |
| Total | $27.2 | $21.6 | $5.6 | 26.0% |
Revenue by geographic region:
| 2Q18Â | 1H18Â | |
| Â U.S. | $11.5Â | $20.1Â |
| Â Ex-U.S. | $3.6Â | $7.1Â |
This is KIDS’ highest reported quarterly revenue ever. While Arthroscopy/Soft Tissue Repair is a very small portion of revenue, no explanation was given for the drop in growth.
KIDS continues to invest in consignment sets, R&D and salesforce expansion. They invested an additional $2.8MM in sets in the quarter, and remain on track to end the year having invested $11.0MM in total. (This is up from the $10.0MM cited in the 1Q earnings call.)
Thirteen domestic reps came on board in 2Q. Four additional systems will launch by year end, including the small stature RESPONSE scoliosis system and an additional BandLok device. R&D is said to be making progress on active growing implants and spinal tethering.
The company raised full-year revenue guidance from +22% vs. 2017; the range is now +23% to +%24% for upwards of $42.0MM.
Source: OrthoPediatrics, Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
